110 related articles for article (PubMed ID: 6138697)
1. The development of a radioimmunoassay for formoterol.
Yokoi K; Murase K; Shiobara Y
Life Sci; 1983 Oct; 33(17):1665-72. PubMed ID: 6138697
[TBL] [Abstract][Full Text] [Related]
2. Quantitative determination of the beta-adrenoceptor stimulant formoterol in urine by gas chromatography mass spectrometry.
Kamimura H; Sasaki H; Higuchi S; Shiobara Y
J Chromatogr; 1982 May; 229(2):337-45. PubMed ID: 6124550
[TBL] [Abstract][Full Text] [Related]
3. Disposition and metabolism of formoterol fumarate, a new bronchodilator, in rats and dogs.
Sasaki H; Kamimura H; Shiobara Y; Esumi Y; Takaichi M; Yokoshima T
Xenobiotica; 1982 Dec; 12(12):803-12. PubMed ID: 7170790
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective urinary excretion of formoterol and its glucuronide conjugate in human.
Zhang M; Fawcett JP; Shaw JP
Br J Clin Pharmacol; 2002 Sep; 54(3):246-50. PubMed ID: 12236843
[TBL] [Abstract][Full Text] [Related]
5. Optimization and validation of a gas chromatographic method for analysis of (RS,SR)-diastereoisomeric impurity in formoterol fumarate.
Akapo SO; Wegner M; Mamangun A; McCrea C; Asif M; Dussex JC
J Chromatogr A; 2004 Aug; 1045(1-2):211-6. PubMed ID: 15378897
[TBL] [Abstract][Full Text] [Related]
6. Quantitative detection of inhaled formoterol in human urine and relevance to doping control analysis.
Deventer K; Pozo OJ; Delbeke FT; Van Eenoo P
Drug Test Anal; 2012 Jun; 4(6):449-54. PubMed ID: 22447497
[TBL] [Abstract][Full Text] [Related]
7. Determination of formoterol in rat plasma by liquid chromatography-electrospray ionisation mass spectrometry.
Kakubari I; Dejima H; Miura K; Koga Y; Mizu H; Takayasu T; Yamauchi H; Takayama S; Takayama K
Pharmazie; 2007 Feb; 62(2):94-5. PubMed ID: 17341025
[TBL] [Abstract][Full Text] [Related]
8. First high-performance liquid chromatography assay of formoterol concentrations in the low-picogram-per-milliliter range.
van den Berg BT; Portier EJ; van den Berg M; Braat MC; van Boxtel CJ
Ther Drug Monit; 1994 Apr; 16(2):196-9. PubMed ID: 7912013
[TBL] [Abstract][Full Text] [Related]
9. Comparison of effects of formoterol and BRL 37344 on isolated term-pregnant rat myometrial strips in vitro.
Yurtcu N; Cetin A; Karadas B; Gonca Imir A; Kaya T; Erselcan T; Bagcivan I; Cetin M
Eur J Pharmacol; 2006 Jan; 530(3):263-9. PubMed ID: 16388799
[TBL] [Abstract][Full Text] [Related]
10. Chiral HPLC analysis of formoterol stereoisomers and thermodynamic study of their interconversion in aqueous pharmaceutical formulations.
Akapo S; McCrea C; Gupta J; Roach M; Skinner W
J Pharm Biomed Anal; 2009 Apr; 49(3):632-7. PubMed ID: 19150186
[TBL] [Abstract][Full Text] [Related]
11. Comparative bioavailability of two hydrofluoroalkane formulations of formoterol fumarate both delivered by pressurised metered dose inhaler.
Po CJ; Chandran SS; Syed N; Naidu KR; Rathod M; Sule A; Lulla A; Purandare S
Arzneimittelforschung; 2010; 60(2):81-6. PubMed ID: 20329656
[TBL] [Abstract][Full Text] [Related]
12. Stereoselective glucuronidation of formoterol by human liver microsomes.
Zhang M; Fawcett JP; Kennedy JM; Shaw JP
Br J Clin Pharmacol; 2000 Feb; 49(2):152-7. PubMed ID: 10671910
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of beta2-adrenoceptors, using the agonist [11C]formoterol and positron emission tomography.
Visser TJ; van Waarde A; Doze P; Elsinga PH; van der Mark TW; Kraan J; Ensing K; Vaalburg W
Eur J Pharmacol; 1998 Nov; 361(1):35-41. PubMed ID: 9851539
[TBL] [Abstract][Full Text] [Related]
14. Effects of formoterol on histamine induced plasma exudation in induced sputum from normal subjects.
Greiff L; Wollmer P; Andersson M; Svensson C; Persson CG
Thorax; 1998 Dec; 53(12):1010-3. PubMed ID: 10195069
[TBL] [Abstract][Full Text] [Related]
15. The effects of formoterol on plasma exudation produced by a localized acute inflammatory response to bradykinin in the tracheal mucosa of rats in vivo.
O'Donnell SR; Anderson GP
Br J Pharmacol; 1995 Sep; 116(1):1571-6. PubMed ID: 8564220
[TBL] [Abstract][Full Text] [Related]
16. High affinity [3H]formoterol binding sites in lung: characterization and autoradiographic mapping.
Mak JC; Grandordy B; Barnes PJ
Eur J Pharmacol; 1994 Sep; 269(1):35-41. PubMed ID: 7828656
[TBL] [Abstract][Full Text] [Related]
17. A simplified procedure for the analysis of formoterol in human urine by liquid chromatography-electrospray tandem mass spectrometry: application to the characterization of the metabolic profile and stability of formoterol in urine.
Mazzarino M; de la Torre X; Fiacco I; Pompei C; Calabrese F; Botrè F
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 931():75-83. PubMed ID: 23777613
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the urinary threshold concentration of formoterol in sports drug testing.
Ventura R; Damasceno LM; Ramírez R; Farré M; Bergés R; Segura J
Drug Test Anal; 2013 Apr; 5(4):266-9. PubMed ID: 23355217
[TBL] [Abstract][Full Text] [Related]
19. The effects of formoterol, a long-acting beta 2-adrenoceptor agonist, on mucociliary activity.
Lindberg S; Khan R; Runer T
Eur J Pharmacol; 1995 Oct; 285(3):275-80. PubMed ID: 8575514
[TBL] [Abstract][Full Text] [Related]
20. Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia.
Cazzola M; Imperatore F; Salzillo A; Di Perna F; Calderaro F; Imperatore A; Matera MG
Chest; 1998 Aug; 114(2):411-5. PubMed ID: 9726723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
